Ignite Creation Date:
2024-05-06 @ 1:40 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01868022
Status:
COMPLETED
Last Update Posted:
2019-08-19
First Post:
2013-05-30
Brief Title:
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor FGF Pathway Signaling
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-24
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-30
First Submit QC Date:
May 30 2013
Study First Post Date:
2013-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-02-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-02
Last Update Post Date:
2019-08-19
Last Update Post Date Type:
ACTUAL